Labshake search
Citations for R&D Systems :
601 - 650 of 2576 citations for Recombinant Human IL12A Fc tagged since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Molecular Biology 2022Quote: ... 10 ng/ml recombinant human brain-derived neurotrophic factor (BDNF) protein (R&D Systems 248-BDB-005), and 10 µM ɣ-secretase inhibitor (DAPT ...
-
bioRxiv - Cell Biology 2022Quote: ... Cells were then treated with 10 ng/ml of recombinant human EGF (236-EG, R&D systems) in RPMI-1640 medium and incubated at 37℃ ...
-
The MuSK-BMP pathway maintains myofiber size in slow muscle through regulation of Akt-mTOR signalingbioRxiv - Cell Biology 2022Quote: ... then treated with 20-25 ng/ml recombinant human BMP4 protein (R&D Systems, Cat# 314-BP). For acetylcholine receptor clustering experiments ...
-
bioRxiv - Immunology 2022Quote: ... 1% PS and 100 IU/ml of human recombinant IL-2 (R&D Systems, 202-IL-050). Cells were used at low passage numbers ...
-
bioRxiv - Pharmacology and Toxicology 2022Quote: ... Recombinant human IL-1β was obtained from R&D Systems (Abingdon, UK; Cat. No. 201-LB/CF) and recombinant murine IFNγ from PeproTech (Rocky Hill ...
-
bioRxiv - Bioengineering 2024Quote: ... recombinant human interferon-γ protein (Cat. #285-IF, lot #RAX2422031, R&D Systems, Minneapolis, Minnesota, United States), Pierce streptavidin poly-horseradish peroxidase (pHRP ...
-
bioRxiv - Immunology 2023Quote: ... The signals were compared to a standard curve generated with recombinant human IL-21 (R&D Systems).
-
bioRxiv - Cell Biology 2022Quote: ... 48 and 96 hours in the presence or absence of recombinant human IL-1β (R&D systems), recombinant human IFNγ (PeproTech ...
-
bioRxiv - Cancer Biology 2023Quote: ... Inhibitors used in the study are Recombinant Human TGF-β1 protein (R&D Systems, 240-B-002), SAHA (Sigma ...
-
bioRxiv - Cancer Biology 2022Quote: ... unconditioned HEI-193 media supplemented with recombinant human CCL21 600 ng/ml (366-6C, R&D Systems) as a positive control ...
-
bioRxiv - Bioengineering 2023Quote: ... supplemented with recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) (50 ng/mL) (R&D Systems) and recombinant human interleukin-4 (IL-4 ...
-
bioRxiv - Bioengineering 2023Quote: ... medium was changed every day to HDM with 20 ng/mL human recombinant HGF (R&D Systems). After 14 to 24 days ...
-
bioRxiv - Cancer Biology 2024Quote: ... recombinant human IL-4 500 IU/mL and GM- CSF 800 IU/mL (both R&D systems) at a cell density of 1-2 x106 cells/mL for 5 days ...
-
bioRxiv - Cell Biology 2024Quote: ... Recombinant human vascular endothelial growth factor-C (VEGF-C) (R&D Systems; #9199-VC; 7.5 ng/mL) was also added to the MV2 full growth medium ...
-
bioRxiv - Immunology 2024Quote: ... human recombinant IFN-α2a (1 µg/ml) and IFN-β (1 µg/ml) proteins (R&D Systems) were reduced using NuPAGE Sample Reducing Agent (10x ...
-
bioRxiv - Neuroscience 2020Quote: ... cells were treated for 1h at 37°C with 5nM of human SEMA3A Fc chimera (R&D System), dissolved in 1x Dulbecco’s PBS (DPBS ...
-
bioRxiv - Neuroscience 2020Quote: ... 100 µl of supernatant samples and standards (recombinant mouse TREM2-FC, 1729-T2; R&D Systems; 0-20 ng/ml in BSA-PBST) were then incubated for 2 hr at RT ...
-
bioRxiv - Immunology 2019Quote: ... Following an overnight culture islets were treated with 200 U/ml recombinant human (h) TNFα (R&D Systems) for 1 ...
-
bioRxiv - Immunology 2019Quote: ... and antibodies were obtained as follows: recombinant human VCAM-1 (#862-VC) from R&D Systems (Minneapolis, MN); recombinant human IL-2 from the NIH AIDS Reagent Program ...
-
bioRxiv - Genomics 2021Quote: ... medium supplemented with 100ng/mL recombinant human/mouse/rat activin A (R&D systems, cat. 338-AC-010) and incubated cells for 18 hours ...
-
Direct intracellular visualization of Ebola virus-receptor interaction by in situ proximity ligationbioRxiv - Microbiology 2020Quote: ... or recombinant human cathepsin L (CatL, 2 ng/ul, pH 5.5, 37°C for 1h; R&D Systems) as described previously (5) ...
-
bioRxiv - Cell Biology 2022Quote: ... Recombinant human PRDX6 (150 μg/mL final) and active MAPK (ERK2, R&D Systems, 10 μg/mL final) were added to 30 μL of a phosphorylation buffer containing 50 mM Tris/HCl pH 7.5 ...
-
bioRxiv - Bioengineering 2022Quote: ... Microvessels with and without 24 h treatment with 5 ng mL-1 human recombinant TNFα (R&D Systems), were perfused with THP1s under low shear stress (∼0.2 dyne cm-2 ...
-
bioRxiv - Bioengineering 2022Quote: ... media in the top compartment was replaced with recombinant human TNFα (0.1 ng/mL, R&D Systems, 210TA) and recombinant human IFNγ (2 IU/mL ...
-
bioRxiv - Cell Biology 2022Quote: ... the beads were introduced to either 20 nM recombinant human GAS6 (R&D Systems, Cat# 885-GSB-050), or recombinant human Protein S (R&D Systems ...
-
bioRxiv - Neuroscience 2020Quote: ... then incubated with various concentrations (0 to 100 nM) of human recombinant tau (2N4R, R&D Systems Inc.) in the absence or presence of RAP (at a 20-fold molar excess compared to the concentration of tau ...
-
bioRxiv - Genomics 2019Quote: ... the media was supplemented with 100 ng/mL recombinant human IFN-γ (285-IF-100; R&D Systems) and cells were incubated for 8 hours prior to harvest ...
-
bioRxiv - Cell Biology 2022Quote: ... or Basal Medium plus 100 ng/ml recombinant human NTN1 (6419-N1, R&D Systems, Minneapolis, MI, USA). Photographs were taken after 4 h of incubation ...
-
bioRxiv - Biochemistry 2019Quote: ... These wells were suspended above wells containing 5 to 10 ng/mL recombinant human VEGF (R&D Systems) or full serum medium ...
-
bioRxiv - Cell Biology 2019Quote: ... Control medium was then augmented with 10 ng/mL recombinant human TGF-β1 (R&D Systems; chondrogenic media) to induce chondrogenesis ...
-
bioRxiv - Molecular Biology 2021Quote: ... Recombinant human TGFβ1 (100-B-001) and Thrombospondin-1 (3074-TH-050) were purchased from R&D Systems. Matrigel-based hydrogel culture system were employed ...
-
bioRxiv - Immunology 2020Quote: ... Recombinant human MFG-E8 protein produced in mouse myeloma cells was purchased from R&D Systems (Minneapolis, MN).
-
bioRxiv - Genomics 2020Quote: ... the media was supplemented with 100 ng/mL recombinant human IFN-γ (285-IF-100; R&D Systems) and cells incubated for 8 hours prior to harvest.
-
bioRxiv - Immunology 2022Quote: ... and then treated with 10 ng/mL of recombinant human TGF-b (R&D Systems; 240-B-002) or 10 ng/mL of recombinant human IL-1β (R&D Systems ...
-
bioRxiv - Molecular Biology 2023Quote: Control and Slc7a7-/- mice were intraperitoneally injected with recombinant human erythropoietin (500 U/kg/day; R&D Systems) daily for three consecutive days ...
-
bioRxiv - Biophysics 2023Quote: ... 10 ng/mL recombinant human transforming growth factor beta 1 (TGF-β1 from R&D System, Minnesota, USA). For 3D cultures ...
-
bioRxiv - Neuroscience 2023Quote: ... cells were treated for 24h with 100ng/ml media of human recombinant GBA (rhGBA-His (R&D Systems)).
-
bioRxiv - Cancer Biology 2023Quote: ... C2C12 cells were treated with ZA in the presence or absence of recombinant human TGFβ1 (R&D Systems).
-
bioRxiv - Cell Biology 2023Quote: ... EBs were formed in an ESC medium depleted of recombinant human FGF-2 (rhFGF-2) (R&D Systems) on day 0 ...
-
bioRxiv - Cell Biology 2023Quote: ... 10 ng/mL heregulin-1β (recombinant human NRG-β 1/HRG-β1 EGF domain; R&D Systems, USA), 200 ng/mL recombinant human IGF-1 (LONG R3-IGF-1 ...
-
bioRxiv - Immunology 2023Quote: PBMC were isolated from whole blood and treated with recombinant human CCL2 (279-MC-010; R&D Systems) at 100 ng/ml ...
-
bioRxiv - Immunology 2022Quote: ... were coated with 100 μl per well of 1.5 μg/ml human recombinant integrin αvβ6 (R&D Systems) diluted in coating buffer from the ELISA Starter Accessory Kit (Bethyl Laboratories ...
-
bioRxiv - Neuroscience 2023Quote: Recombinant Human Neuronal Pentraxin 1 Protein (NP1) was purchased from R&D systems (#: 7707-NP, bio-techne, USA).
-
bioRxiv - Microbiology 2023Quote: ... Cells were pretreated with vehicle or 50 ng/mL recombinant human IL-8 (rhIL-8, R&D Systems) 12 h before scratch assay ...
-
bioRxiv - Bioengineering 2023Quote: ... medium was changed every day to HDM with 20 ng/mL human recombinant BMP-4 (R&D Systems) and 20 ng/mL human recombinant FGF-4 (R&D Systems) ...
-
bioRxiv - Cell Biology 2024Quote: ... the cells were stimulated with 2 ng/mL recombinant human TGF-β1 (R&D Systems, cat. # 240-B) diluted in starvation medium for varying durations of 30 ...
-
bioRxiv - Cancer Biology 2024Quote: ... ENAS + 5 ng/ml TGF-β1 (Recombinant Human TGF-β1 Protein, R&D Systems, Cat. No. 240-B). Basal medium + solvent ...
-
bioRxiv - Immunology 2024Quote: ... NK cells were cultured in RP10 supplemented with 300 IU/ml recombinant human IL-2 (R&D Systems) for 72 h unless otherwise noted ...
-
bioRxiv - Bioengineering 2024Quote: ... This was done by incubating 100 µg of recombinant human G-CSFR (381-GR/CF, R&D Systems) in 950 µL PBS for 2 h at room temperature (RT ...
-
bioRxiv - Immunology 2024Quote: ... or CEFTA were supplemented with 10IU/mL of recombinant human IL-2 (rh IL-2; R&D Systems) and 10ng/mL of recombinant human IL-7 (rh IL-7 ...